Description
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Trial to Evaluate the Efficacy and Safety of a Single Treatment of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia(ASPEN-1)
Please contact simr@sutterhealth.org about Study ASPEN-1 CD
Location: SIMR (Sacramento/Valley Area)
View study details on ClinicalTrials.govPrincipal Investigator
Recruitment Status
Active, Recruiting
Start Date
February 01, 2019
Related Studies
GXCA
Gene Expression of Cerebral Aneurysms // [EMC]
Investigator: Lawrence Dickinson, M.D
Genetics and Comorbidity of Migraine
Identify common genetic variants for migraine to determine whether there are single
nucleotide polymorphisms associated with migraine.
Investigator: Alice R. Pressman, Ph.D., M.S.
Mindfulness and Migraine: A Randomized Controlled Trial
Conduct a randomized controlled feasibility trial of mindfulness-based stress reduction
for patients with moderate-to-severe migraine headache.
Investigators: Sylvia Sudat, PhD, Alice R. Pressman, Ph.D., M.S.
Using Electronic Health Records to Identify Gaps in Migraine Headache Care: A Step Towards Improving Patient Outcomes
Use EHRs and survey data to characterize migraineurs at Sutter Health by demographic,
comorbidity, symptom, and care gap profiles, to see if tx needs are met.
Investigator: Alice R. Pressman, Ph.D., M.S.